ACTIVITY OF NIAMID® AGAINST MYCOBACTERIUM TUBERCULOSIS AND CROSS RESISTANCE TO ISONIAZID
Editor, The American Journal of Psychiatry:
George A. Klugh 1,
Philip C. Pratt 1, , and
Robert J. Atwell 1
1 Ohio Tuberculosis Hosp., Columbus, Ohio.
This study shows that there is cross resistance of tubercle bacilli to Niamid® and Isoniazid. When Niamid is administered to a patient, thorough studies should be carried out to determine if the patient also has active tuberculosis. If so, a second anti-tuberculous drug should also be used, in accordance with currently established principles of combined drug therapy for tuberculosis.
